Pete Farley

Science and Public Health in the Post-Pandemic Age

Carl Zimmer of the New York Times and CZ Biohub Co-President Joe DeRisi discussed the impact of COVID-19 on science and public health

In 2017, acclaimed New York Times journalist Carl Zimmer and CZ Biohub Co-President Joe DeRisi met on stage in San Francisco at the World Conference of Science Journalists for a wide-ranging discussion. In particular, they touched on how genomic technologies championed by DeRisi were transforming the detection and diagnosis of infectious diseases, including how these tools might form the basis of a global early-warning system for emerging pandemics.

Now, just four years later, in-person conferences are a rarity, as we try to regain our footing in the wake of a devastating pandemic that spread like wildfire and profoundly reshaped societies on a global scale.

On July 15, in an event sponsored by the Northern California Science Writers Association, DeRisi and Zimmer met again, this time via Zoom, to discuss the impact of COVID-19 on science and public health, and to provide a glimpse of our path forward.

News

  • International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease

    Biohub, the U.S. Department of Energy, the National Institutes of Health, and new funding partners today announced a major expansion of an international effort to generate and make accessible the data enabling predictive AI models of …

  • TIME: 100 AI List (2026)

    Biohub Head of Science, Alex Rives, is named to the TIME100 AI list

  • Why one drug isn’t enough: AI reveals cancer’s secret weapon – and how to beat it

    Tumors are patchworks of distinct malignant cell states, each with its own survival strategy. With AI, Biohub scientists are discovering drug combinations that defeat them all at once.